Atezolizumab‐related sclerosing cholangitis with multiple liver abscesses in a patient with lung squamous cell carcinoma: A case report

Atezolizumab‐related sclerosing cholangitis with multiple liver abscesses in a patient with lung squamous cell carcinoma: A case report

Abstract A 76‐year‐old man underwent an operation for lung squamous cell carcinoma in the right lower lobe, followed by initial adjuvant therapy with atezolizumab, an antibody against anti‐programmed death‐ligand 1 (PD‐L1). On day 4 after atezolizumab treatment, the patient developed general malaise...

Full description

Bibliographic Details
Main Authors: Daisuke Jingu, Akira Horii, Takehiro Yajima, Ryuta Ohira, Satoshi Ubukata, Kosuke Satou, Hiroshi Takahashi, Hiroshi Watanabe, Hiroyuki Funayama
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Respirology Case Reports
Subjects:
atezolizumab
immune checkpoint inhibitor
immune‐related adverse events
liver abscess
sclerosing cholangitis
Online Access:https://doi.org/10.1002/rcr2.1324

Internet

https://doi.org/10.1002/rcr2.1324

Similar Items